AVITA Medical, Inc. (RCEL) Gross Profit (2018 - 2026)

AVITA Medical (RCEL) has reported Gross Profit for 9 consecutive years, with $17.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit rose 18.85% year-over-year to $17.8 million; the trailing twelve-month figure through Jun 2026 stood at $60.9 million (down 3.5% YoY), and the FY2025 full-year result was $58.8 million, up 6.63% from the prior year.
• Gross Profit grew to $17.8 million in Q2 2026 per RCEL's latest filing, from $14.3 million in the prior quarter.
• Across five years, Gross Profit topped out at $17.8 million in Q2 2026 and bottomed at $5.8 million in Q1 2022.
• Historically, Gross Profit has averaged $12.2 million across 5 years, with a median of $12.7 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Gross Profit tumbled 63.65% in 2022, then surged 63.5% in 2025.
• Over 5 years, Gross Profit stood at $8.1 million in 2022, then jumped by 52.92% to $12.4 million in 2023, then soared by 30.06% to $16.1 million in 2024, then decreased by 11.26% to $14.3 million in 2025, then increased by 24.15% to $17.8 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $17.8 million, $14.3 million, and $13.9 million for Q2 2026, Q4 2025, and Q3 2025 respectively.